Today is Election Day and Kentuckians will be at the polls casting their votes. Follow along for updates around.

The severe asthma market is fueled by the rising prevalence of the condition, particularly in urban areas, alongside the emergence of innovative therapies ...

The Company is guiding to Q4 2024 revenues of $36 to $38 million. The Company anticipates Core revenues in Q4 2024 of $35 to $37 million, which includes $1 to $2 million of Risk Assessment testing ...

For people suffering from various rare forms of blood cancer, acalabrutinib offers the promise of improved life quality by reducing serious side effects — namely suppressed immune systems that left ...

"Record gold prices generated higher revenues, Adjusted EBITDA and earnings in Q3 compared to Q2 2024," stated Paul Brink, CEO. "GEO sales were stable compared to Q2 although lower compared to Q3 2023 ...

Meet representatives from county departments and local nonprofits offering resources like FEMA application assistance, free ...

Sera Prognostics Inc., The Pregnancy Company® , focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced ...

Safety concerns remain a significant barrier to appropriate referral from oncology teams, to use by acupuncturists and to ...